Reves R - Search Results

1

In reply: We and our patients must demand better TB diagnostics.

Belknap R, Reves R. Belknap R, et al. Among authors: reves r. Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1316. doi: 10.5588/ijtld.17.0458-2. Int J Tuberc Lung Dis. 2017. PMID: 29297457 No abstract available.

2

Is it time to rethink the role of AFB smears?

Belknap R, Reves R. Belknap R, et al. Among authors: reves r. Int J Tuberc Lung Dis. 2017 Jul 1;21(7):720. doi: 10.5588/ijtld.17.0323. Int J Tuberc Lung Dis. 2017. PMID: 28633694 No abstract available.

3

Pacemaker wire infection with Mycobacterium tuberculosis: a case report and literature review.

Kestler M, Reves R, Belknap R. Kestler M, et al. Among authors: reves r. Int J Tuberc Lung Dis. 2009 Feb;13(2):272-4. Int J Tuberc Lung Dis. 2009. PMID: 19146760 Review.

4

Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.

Ho CS, Feng PI, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ; Tuberculosis Epidemiologic Studies Consortium. Ho CS, et al. Among authors: reves r. Lancet Infect Dis. 2022 Jan;22(1):85-96. doi: 10.1016/S1473-3099(21)00145-6. Epub 2021 Sep 6. Lancet Infect Dis. 2022. PMID: 34499863 Free PMC article.

5

High Rates of Tuberculosis and Opportunities for Prevention among International Students in the United States.

Collins JM, Reves RR, Belknap RW. Collins JM, et al. Among authors: reves rr. Ann Am Thorac Soc. 2016 Apr;13(4):522-8. doi: 10.1513/AnnalsATS.201508-547OC. Ann Am Thorac Soc. 2016. PMID: 26730745

6

Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab.

Belknap R, Reves R, Burman W. Belknap R, et al. Among authors: reves r. Int J Tuberc Lung Dis. 2005 Sep;9(9):1057-8. Int J Tuberc Lung Dis. 2005. PMID: 16158902 No abstract available.

7

Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis.

Gray J, Reves R, Johnson S, Belknap R. Gray J, et al. Among authors: reves r. Clin Infect Dis. 2012 Feb 1;54(3):e20-3. doi: 10.1093/cid/cir792. Epub 2011 Nov 4. Clin Infect Dis. 2012. PMID: 22057704

8

Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy.

Belknap R, Weis S, Brookens A, Au-Yeung KY, Moon G, DiCarlo L, Reves R. Belknap R, et al. Among authors: reves r. PLoS One. 2013;8(1):e53373. doi: 10.1371/journal.pone.0053373. Epub 2013 Jan 7. PLoS One. 2013. PMID: 23308203 Free PMC article.

9

Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.

De Groote MA, Higgins M, Hraha T, Wall K, Wilson ML, Sterling DG, Janjic N, Reves R, Ochsner UA, Belknap R. De Groote MA, et al. Among authors: reves r. J Clin Microbiol. 2017 Feb;55(2):391-402. doi: 10.1128/JCM.01646-16. Epub 2016 Nov 16. J Clin Microbiol. 2017. PMID: 27852671 Free PMC article.

10

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.

Belknap R, Holland D, Feng PJ, Millet JP, Caylà JA, Martinson NA, Wright A, Chen MP, Moro RN, Scott NA, Arevalo B, Miró JM, Villarino ME, Weiner M, Borisov AS; TB Trials Consortium iAdhere Study Team. Belknap R, et al. Ann Intern Med. 2017 Nov 21;167(10):689-697. doi: 10.7326/M17-1150. Epub 2017 Nov 7. Ann Intern Med. 2017. PMID: 29114781 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters